The product meets the standards of the Chinese Pharmacopoeia, the Chinese Veterinary Pharmacopoeia, EP, USP, and other standards. The product has obtained European CEP and US FDA certification.
introduce
Oxytetracycline works by inhibiting bacterial protein synthesis, specifically by binding to the bacterial ribosome and preventing the attachment of aminoacyl-tRNA to the acceptor site. This leads to the inhibition of bacterial growth and replication.
